PHP8 AN ECONOMIC MODEL FOR COOPERATION BETWEEN A NOT-FOR-PROFIT HMO AND A PHARMACEUTICAL COMPANY IN A DISEASE MANAGEMENT PROGRAM:TRANSFORMING CONFLICT OF INTERESTS INTO UTILITY MAXIMIZATION

Shavit, O ; Raz, M ; Chen, M ; Blay, A ; Friedman, N ; Hoffman, A

Elsevier Inc

Texto completo disponível

RWD12 Wayfind-R: A Global, Real-World Precision Oncology Registry – Socioeconomic Features

Hackshaw, A. ; Dienstmann, R. ; Blay, J.Y. ; Le Tourneau, C. ; Geissler, J. ; Ferro, A. ; Schirghuber, E. ; Skatkova, O.

Texto completo disponível

EE64 Change in Healthcare Resource Use and Associated Costs of Patients with Metastatic Lung Cancer between 2013 and 2019: An Observational Study from the French National Claims Database

Chouaid, C. ; Marchal, C. ; Apert, M. ; Bensimon, L. ; Guimard, V. ; Née, M. ; Belhassen, M. ; de Pouvourville, G. ; Blay, J.Y.

Texto completo disponível

POSB342 Time Until Definitive Deterioration (TUDD) in Patient Reported Outcomes (PROS) in a Phase 3 Trial for Ripretinib in 4L Patients with Gastrointestinal Stromal Tumour (GIST)

Becker, C ; Harrow, B ; Heinrich, MC ; Schöffski, P ; Serrano, C ; Vincenzi, B ; BLAY, JY

Elsevier Inc

Texto completo disponível

P63 Patient-Reported Outcomes Following Treatment with Vimseltinib for Tenosynovial Giant Cell Tumour in a Phase 2 Expansion Study

Blay, JY ; Gelderblom, H ; Rutkowski, P ; Wagner, AJ ; van de Sande, M ; Stacchiotti, S ; Le Cesne, A ; Palmerini, E ; Vallee, M ; Harrow, B ; Becker, C ; Jarecha, R ; Sharma, M ; Tap, WD

Elsevier Inc

Texto completo disponível

P61 Health State Utility Values and Quality of Life in Patients Receiving Ripretinib in the Phase 3 Invictus Trial and a Real-World Evidence Study in China

Jones, RL ; Blay, JY ; Chi, P ; Bauer, S ; Gelderblom, H ; Shen, L ; He, YL ; Heinrich, MC ; Schöffski, P ; Zalcberg, JR ; Harrow, B ; Sherman, ML ; Ruiz-Soto, R ; Becker, C ; von Mehren, M

Elsevier Inc

Texto completo disponível

EE608 Cost Effectiveness Analysis of a Large (Foundation Medicine) Versus a Home-Based Medium Gene Panel for Exome Sequencing: Results of the Profiler 02 Randomized Clinical Trial

Perrier, L ; Tredan, O ; Morelle, M ; Penel, N ; Fournel, P ; Greillier, L ; Ghiringhelli, F ; Tosi, D ; Bertucci, F ; Campone, M ; Delord, JP ; Pouessel, D ; Garin, G ; Chabaud, S ; Gomez-Roca, C ; Pannier, D ; Brahmi, M ; Fabbro, M ; Garcia, ME ; Ray-Coquard, I ; Viala, M ; Italiano, A ; Cassier, P ; Dufresne, A ; Attignon, V ; Treilleux, I ; Viari, A ; de la Motte Rouge, T ; Durando, X ; Perol, D ; Blay, JY

Elsevier Inc

Texto completo disponível

Economic Impact of Centralized Histological Reviews in Patients with Sarcoma, Gist, and Desmoid Tumors

Perrier, L ; Kembou, Nzale S ; Rascle, P ; Bui, B ; Morelle, M ; Ranchère, Vince D ; Terrier, P ; Neuville, A ; Decouvelaere, A.V ; Le Cesne, A ; Gomez, F ; de la Fouchardière, C ; Meeus, P ; Trédan, O ; Pérol, M ; Fayette, J ; Neidhardt, E.M ; Biron, P ; Boyle, H.J ; Marec, Bérard P ; Farsi, F ; Ducimetière, F ; Blay, J.Y ; Ray, Coquard I ; Coindre, J.M

United States

Texto completo disponível

Management of Soft Tissue Sarcoma in France - A Retrospective Analysis of The French Clinical Biological Sarcoma Database (CONTICANET)

Coindre, J ; Ducimetière, F ; Mathoulin-Pelissier, S ; Le Cesne, A ; Rochaix, P ; Terrier, P ; Longin, J ; van Hille, B ; Bui Ngyuen, B ; Giraud, A ; Sana, C ; Blay, J

Texto completo disponível

PCN37 - Management of Soft Tissue Sarcoma in France - A Retrospective Analysis of The French Clinical Biological Sarcoma Database (CONTICANET)

Coindre, J ; Ducimetière, F ; Mathoulin-Pelissier, S ; Le Cesne, A ; Rochaix, P ; Terrier, P ; Longin, J ; van Hille, B ; Bui Ngyuen, B ; Giraud, A ; Sana, C ; Blay, J

Elsevier Inc

Texto completo disponível